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Promoter activity of the HIV-1 long terminal repeat (LTR) is largely dependent on intact NF-kB and SpI binding sites in the U3 region. In
contrast, upstream LTR sequences allow efficient simian immunodeficiency virus (SIVmac) transcription in the absence of the core enhancer
promoter region. In the present study, we investigated whether the regulation of HIV-2 Rod LTR activity is more reminiscent of HIV-1 having
the same host or of SIVmac239 belonging to the same phylogenetic group. Viral promoter activity was studied in the context of the integrated
provirus using both single cycle assays with pseudotyped luciferase reporter viruses and replication-competent HIV-2 LTR mutants. Our
results demonstrate that intact SpI binding sites are important for both HIV-2 and SIVmac LTR activity in T cells and monocyte-derived
macrophages. In contrast, deletion of the NF-kB binding site or of upstream regulatory sequences impaired HIV-2 Rod LTR activity but had
little effect on SIVmac239 promoter function. Thus, similar to HIV-1, regulation of HIV-2 LTR promoter activity shows a low degree of
functional redundancy possibly suggesting a specific adaptation to the human host.
D 2004 Elsevier Inc. All rights reserved.Keywords: SIV; HIV-2; LTR; Transcription; PromoterIntroduction
Efficient transcription of the retroviral genome depends
on the activity of the viral promoter, which is in the long
terminal repeat (LTR) at the 5V end of the proviral genome.
Each LTR consists of three regions, U3, R, and U5 (Varmus,
1988). The U3 region of primate lentiviruses contains
sequences required for integration into the host cell genome
and major transcriptional control elements: the TATA box
motif and binding sites for the cellular transcription factors
NF-nB and Sp1 (Gaynor, 1992; Jones et al., 1986; Kawa-
kami et al., 1988; Nabel and Baltimore, 1987). Transcrip-
tional activity of HIV-1, the main causative agent of AIDS,
is usually dependent on intact NF-nB and Sp1 binding sites
(Perkins et al., 1993; Ross et al., 1991). The two NF-nB0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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spread in primary cells (Alcami et al., 1995; Chen et al.,
1997), but might be less critical in Jurkat cells (Lu et al.,
1991). Similarly, the relevance of intact Sp1 cells for HIV-1
replication is dependent on both the viral strain and the
target cell type (Koken et al., 1992; Parrott et al., 1991). In
contrast to HIV-1 (Ross et al., 1991), even combined
deletion of the NF-nB and all four Sp1 binding sites had
little impact on the transcriptional activity of the simian
immunodeficiency virus (SIVmac239) LTR (Ilyinskii and
Desrosiers, 1996; Pohlmann et al., 1998). Notably, SIV-
mac239 without NF-nB and Sp1 binding sites replicated
efficiently and caused disease in infected rhesus macaques
(Ilyinskii et al., 1997).
The second causative agent of AIDS in humans, HIV-2,
is genetically closely related to SIVmac, and both originate
from naturally infected sooty mangabeys (Hahn et al.,
2000). In contrast, HIV-1 was most likely transmitted into
the human population from infected chimpanzees (Hahn et
al., 2000). The NF-nB and Sp1 binding sites in the LTR
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ces just upstream of the core enhancer elements in the
HIV-1, HIV-2, and SIVmac LTRs show little homology.
For the HIV-2 LTR PuB1, PuB2, pets (peri-Ets), and peri-
nB binding elements have been identified just upstream of
the NF-nB binding site (Clark et al., 1995; Leiden et al.,
1992; Markovitz et al., 1990, 1992). Together with the NF-
nB sites, these binding sites for Ets transcription factors
might mediate the responsiveness of the HIV-2 LTR to T
cell activation. The peri-nB binding elements seem to play
an important role for HIV-2 promoter activity in monocytic
cell lines and macrophages (Clark et al., 1995). PuB1 and
PuB2 binding elements have also been identified in the
SIVmac239 LTR (Pohlmann et al., 1998; Winandy et al.,
1992). However, they are located at different positions and
show only limited homology to the sites found in the HIV-
2 promoter.
Previous results suggest that the transcriptional activity
of the HIV-1 5V LTR is dependent on intact NF-nB and
Sp1 binding sites (Alcami et al., 1995; Chen et al., 1997;
Perkins et al., 1993; Ross et al., 1991). In contrast, a
regulatory element located immediately upstream of the
NF-nB binding site allows efficient transcription and
replication of SIVmac239, even in the absence of the
entire core enhancer region (Pohlmann et al., 1998). The
regulation of HIV-2 LTR promoter activity has been
extensively investigated (Arya, 1990; Clark et al., 1995;
Hannibal et al., 1993, 1994; Hilfinger et al., 1993; Leiden
et al., 1992; Markovitz et al., 1990, 1992; Tong-Starksen et
al., 1990). However, most data were obtained in immor-
talized cell lines transfected with LTR reporter constructs.
These results might not accurately reflect the situation in
HIV-2-infected cells because chromatin organization plays
a major role in transcriptional regulation of the integrated
provirus (Pazin et al.,1996; Verdin et al., 1993). Frequent-
ly, LTR variants analyzed in these studies contained alter-
ations outside of the NF-nB and Sp1 binding sites.
Furthermore, expression of many transcription factors is
cell-type dependent, and the impact of intact NF-nB and
Sp1 binding sites on the transcriptional activity in primary
cells that are also target to HIV-1 infection in vivo remains
to be clearly defined.
In the present study, we analyzed the influence of
deletions in the NF-nB and Sp1 binding sites and the
region just upstream of the core enhancer elements in the
HIV-2 and SIVmac LTR on transcriptional activity of the
integrated provirus and on viral replication. Our results
demonstrate that the SpI binding sites are important for
5V LTR transcriptional activity of both HIV-2 and SIV-
mac. In contrast, deletion of the NF-nB binding site or
upstream regulatory elements impaired efficient proviral
transcription of the HIV-2 LTR, but had negligible effects
on SIVmac promoter activity and replication. Thus, the
SIVmac239 U3 region shows a higher degree of func-
tional redundancy than the corresponding HIV-2 Rod LTR
region.Results
Rationale for mutant construction
We have previously found that the functional organiza-
tion of the SIVmac239 enhancer differs from that of HIV-1
(Pohlmann et al., 1998). A region located immediately
upstream of the NF-nB binding site in the SIVmac LTR,
containing an Elf-1 binding site, allows efficient viral
replication in the absence of the entire core enhancer region.
In the present study, we investigated the requirement of the
core enhancer and upstream regulatory elements for HIV-2
Rod LTR promoter activity. For direct comparison, the
mutated HIV-2 Rod and SIVmac239 LTRs were inserted
at the 3V end of the env-deleted pBR-Rod10e-n-Luc proviral
genome, in which the nef gene was replaced with the
luciferase reporter gene (Fig. 1). We utilized the HIV-2
Rod and SIVmac239 LTRs because these two molecular
clones have been thoroughly characterized and are consid-
ered prototype strains. Pseudotyped viral particles were
generated by co-transfection of 293T cells with the proviral
construct and a vector expressing VSV-G as described
elsewhere (Hiebenthal-Millow and Kirchhoff, 2002). Sub-
sequently, these virions were used in single round of
infection assays. During reverse transcription, the mutated
3Vpromoter sequences are copied to both the 5Vand 3VLTRs
of the provirus and drive transcription of the viral genome.
Therefore, this experimental system is useful to readily
assess the transcriptional activity of the viral 5V LTR by
luciferase assay in the context of the integrated provirus. As
shown in Fig. 1, HIV-2 and SIVmac LTR variants contain-
ing deletions in the Sp1 and NF-nB binding sites and
upstream PuB1, pets, PuB2, SF1–3, and peri-nB motifs
(Clark et al., 1995; Leiden et al., 1992; Markovitz et al.,
1990, 1992; Pohlmann et al., 1998) were constructed for
functional analysis. As a negative control, a LTR deletion
mutant containing a deletion of all U3 sequences between
the att-region and the TATA-Box named Rod10D3LTR was
constructed. This variant contained an intact 5VLTR and all
sequences required for reverse transcription and integration
at the 3V end of the proviral genome but missed the entire
enhancer and modulatory region.
The NF-jB binding site is more important for HIV-2 than
for SIV LTR promoter activity
The human T cell lines PM1, Jurkat, and SupT1 were
infected with HIV-2 particles pseudotyped with the VSV
glycoprotein. Notably, these cell lines contain different basal
levels of nuclear NF-nB (Chen et al., 1997). PM1 cells
express higher levels than Jurkat cells, but both contain
constitutively active NF-nB in their nuclei. In contrast, no
NF-nB is present in nuclear extracts of uninduced SupT1
cells. As shown in Fig. 2, all deletions in the HIV-2 Rod LTR
impaired promoter activity in the three T cell lines investi-
gated. Unexpectedly, deletion of the three Sp1 binding sites
Fig. 1. HIV-2 Rod LTR variants analyzed. The upper panel shows the modified HIV-2 Rod genome. As described in Materials and methods, the env gene was
inactivated by a frame shift mutation, nef was replaced with the luciferase reporter gene, and the 3V LTR with the mutant HIV-2 and SIVmac promoters. The
lower panel indicates schematically the position of several cis-acting regulatory elements and the position of the mutations in the HIV-2 and SIV U3 region.
The corresponding region of the HIV-1 LTR is shown for comparison. Abbreviations: PPT, polypurine tract; USF, upstream stimulatory factor; Ets, ETS-family
transcription factor; PuB, purine-rich box; SF, simian factor.
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to about 20% as compared to the Rod10 wild-type (wt) LTR.
The luciferase reporter activities detected after infection with
the remaining HIV-2 Rod LTRmutants were generally below
10%. Thus, intact Sp1 and NF-nB binding sites, as well as the
upstream regulatory sequences, are required for efficient
transcription of the HIV-2 Rod LTR in T cell lines (Fig. 2,
left panel). Different results were obtained with the proviral
HIV-2 constructs containing SIVmac239 promoter sequen-
ces. Deletion of the Sp1 binding site in the SIVmac LTR had
severe disruptive effects and reduced transcriptional activity
at least 10-fold as compared to the 239wt LTR activity (Fig. 2,
right panel). In contrast, deletion of the NF-nB binding site
only reduced promoter activity in PM1 cells, expressing high
levels of NF-nB. However, this deletion had little if any
disruptive effects in Jurkat and SupT1 cells that express loweramounts of this transcription factor. Mutation of the region
just upstream of the core enhancer did not reduce SIVmac
LTR transcriptional activity. As expected from previous
studies (Ilyinskii and Desrosiers, 1996; Ilyinskii et al.,
1997; Pohlmann et al., 1998), deletion of both the NF-nB
and Sp1 binding sites still allowed about 10% of 239wt LTR
activity in Jurkat and PM1 cells. These data demonstrate that
in established human T cell lines efficient proviral transcrip-
tion by the HIV-2 Rod but not the SIVmac239 LTR is
dependent on an intact NF-nB binding site and on the
upstream regulatory sequences.
The effects of LTR mutations on transcriptional activity
are cell-type dependent. Therefore, we next transduced the
monocytic cell line U937 as well as primary human periph-
eral blood mononuclear cells (PBMC) and monocyte-derived
macrophages (MDM) with the HIV-2 Rod10 and SIVmac239
Fig. 3. Promoter activity of HIV-2 and SIV-LTR variants in U937 cells and
human PBMC or MDM. Cells were isolated and cultured as described in
Materials and methods and transduced in triplicate with pseudotyped viral
particles containing 600 ng p27 antigen. Average luciferase activities (cps)
obtained for the HIV-2 Rod LTR (U937: 5161; PBMC: 4415; and MDM:
2971) were comparable to those obtained for the SIVmac239 LTR (U937:
6715; PBMC: 4827; andMDM: 2980). Similar results were obtained in three
independent experiments using PBMC and MDM derived from different
donors.
Fig. 2. Transcriptional activities of mutated HIV-2 and SIVmac promoters.
PM1, Jurkat, and SupT1 cells were transduced with HIV-2 particles
pseudotyped with the VSV-G Env protein normalized to contain 600 ng p27
antigen. Promoter activities relative to the HIV-2 wt-LTR or SIV wt-LTR
(100%) together with standard errors are shown. The average luciferase
activities (cps, counts per second) obtained for the Rod LTR (PM1: 6974;
Jurkat: 6003; and SupT1: 5275) were slightly lower than those obtained for
the 239wt LTR (PM1: 7288; Jurkat: 7606; and SupT1: 6748). Infections
were performed in triplicate, and the results were confirmed in two
independent experiments with different virus stocks.
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line, all mutations in the HIV-2 Rod LTR investigated
reduced transcriptional activity (Fig. 3, left panel). Interest-
ingly, the HIV-2 DSp1 LTR variant maintained about 30–
50% of wt activity in both PBMC and MDM, whereas all
remaining mutants were grossly defective. Thus, the NF-nB
binding site and the upstream regulatory sequences encom-
passing the PuB1, PuB2, pets, and peri-nB binding sites are
required for efficient HIV-2 Rod LTR transcription in primary
cells, whereas the three Sp1 binding sites are less critical. In
contrast, deletion of the Sp1 binding site in the 239wt LTR
strongly reduced transcriptional activity (Fig. 3, right panel).
In contrast to findings with the HIV-2 Rod LTR, deletion of
the NF-nB binding site or mutations of the upstream regula-
tory sequences had less impact on transcriptional activity of
the SIVmac LTR. Relative to the 239wt LTR, the DNF-nBvariant maintained about 60% activity in PBMC and about
30% activity in MDM and U937 cells. Only the deletion of
the core enhancer region in combination with the mutation of
the upstream regulatory element in the SIVmac LTR entirely
disrupted transcriptional activity (DNF/Sp/mSF; Fig. 3, right
panel). These results demonstrate that intact Sp1 binding
regions are more important for SIVmac than for HIV-2 Rod
LTR promoter activity. In comparison, the NF-nB binding
site as well as the upstream regulatory elements are critical for
efficient transcription of the HIV-2 Rod but not the SIVmac
Fig. 5. Virus production by PBMC infected with HIV-2 LTR variants. The
results represent RT production measured in PBMC culture supernatants at
nine time points between 2 and 21 days postinfection with virus stocks
containing 5 ng p24 antigen. For each variant, we first determined the
cumulative RT production as the sum of nine measurements and
subsequently calculated virus production as a percentage of the wild-type
HIV-2 or SIVmac LTR values. Infections, sampling, and RT measurements
were done at the same time for direct comparison. Data (mean values F
standard deviation) were obtained from infection of PBMC derived from
five different donors.
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redundancy compared to the HIV-1 and HIV-2 promoters.
Replication of HIV-2 LTR variants
The mutated HIV-2 Rod and SIVmac239 LTRs were
inserted into the genome of the replication-competent pro-
viral Rod10 clone containing an intact env gene to assess
their effect on viral replication. Virus stocks were produced
by transient transfection of 293T cells, and low doses were
used for infection to minimize the risk of recombination
between the 5V and 3V LTRs. Consistent with the results of
the single round of infection assays, all variants containing
mutated HIV-2 Rod LTRs replicated with reduced efficiency
and delayed kinetics in Jurkat T cells (Fig. 4A, left panel)
and human PBMC (Fig. 4B, left panel). In comparison,
deletion of the NF-nB binding site or mutation of the
upstream regulatory sequences (mSF1–3) in the SIVmac
LTR did not significantly reduce the efficiency of viral
replication. To investigate the possible recombinations be-
tween the 5V and 3V LTRs, we extracted the genomic DNA
at the end of culture for PCR analysis. Fragments of correct
size were amplified from most Jurkat and PBMC samples,
except those infected with the HIV-2 Rod DNF/Sp and
DNF/Sp/US or 239 DNF/Sp/mSF LTR variants, which
showed little if any replication (Fig. 4) and yielded no
PCR product. Sequence analysis confirmed the presence
of the desired mutations in the U3 region of all HIV-2 LTR
variants analyzed (data not shown).
The efficiency of HIV-2 replication depends to some
extent on the PBMC donor. To address this, we infected
cells derived from five different donors with the HIV-2 Rod
LTR mutants. As summarized in Fig. 5, individual deletions
of the NF-nB or Sp1 binding sites or the upstream regulatory
sequence in the HIV-2 Rod LTR reduced virus production to
about 20% compared to the construct containing the parental
HIV-2Rod LTR. Combined deletions of these regulatory
HIV-2 LTR elements almost entirely disrupted viral replica-
tion (Fig. 5, left panel). In comparison, PBMC infected with
HIV-2 clones containing the SIVmac DNF-nB or mSF LTRsFig. 4. Replication of HIV-2 LTR mutants in Jurkat cells (A) and PBMC (B). Cel
replication was determined by reverse transcriptase assay. Shown are the result
independent experiments. Abbreviations: RT, reverse transcriptase.produced almost the same quantities of RT activity as the
clone containing the 239wt LTR (Fig. 5, right panel). The
disruptive effect of combined deletions of the Sp1 and NF-
nB binding sites in the SIVmac LTR on virus production was
also less severe than the corresponding deletions in the HIV-
2 LTR (Fig. 5). As expected, the HIV-2 D3LTR control
construct in which the entire enhancer region was deleted did
not show significant levels of replication.Discussion
In this report, we show that efficient transcription of the
HIV-2 Rod LTR in both T cells and macrophages requiresls were infected with virus stocks containing 5 ng of p27 antigen, and viral
s of one representative experiment. Similar results were obtained in four
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upstream regulatory sequences including PuB1, PuB2, pets,
and the peri-nB site. In contrast, consistent with our previ-
ous study (Pohlmann et al., 1998), the NF-nB binding site
and intact upstream regulatory SF1, SF2, SF3, or PuB2 sites
were not critical for SIVmac239 LTR promoter activity.
HIV-2 and SIVmac share 75% or more sequence homology
and are both derived from naturally infected sooty manga-
beys (Hahn et al., 2000). For detailed functional compari-
son, we inserted mutated HIV-2 and SIVmac LTRs in a
constant genetic background, the well-characterized HIV-2
Rod10 molecular clone (Ryan-Graham and Peden, 1995), to
directly compare the relevance of conserved functional LTR
elements on viral transcription and replication. Our data
clearly demonstrate that the enhancer promoter region of
HIV-2 Rod functions quite differently from that of SIV-
mac239. Most notably, the single NF-nB binding site and
upstream regulatory sequences are critical for HIV-2 Rod
but not for SIVmac LTR promoter activity. It has been
previously shown that the two NF-nB binding sites in the
HIV-1 LTR are highly important for enhancer–promoter
activity in activated T cells, but not absolutely required for
efficient viral replication or for the ability of HIV-1 to cause
AIDS (Zhang et al., 1997). Taken together, these studies
suggest clear differences in the functional organization of
the promoter–enhancer regions of HIV-1, HIV-2 Rod, and
SIVmac239.
The HIV-2 and SIVmac LTRs contain purine-rich
(PuB) binding sites that bind to members of the Ets
family of proto-oncogenes (Leiden et al., 1992; Markovitz
et al., 1990; Pohlmann et al., 1998). Deletion of these
elements impaired HIV-2 transcriptional activity and viral
replication in both T cells and macrophages even in the
presence of intact core promoter–enhancer elements. In
strict contrast, the U3 region upstream of the NF-nB site
in the SIVmac LTR allows efficient viral replication in the
absence of all core enhancer elements, but has little effect
on the transcriptional activity or SIVmac replication in the
presence of either NF-nB or Sp1 binding sites (Pohlmann
et al., 1998). These findings imply that the functional
redundancy of the U3 regions of the HIV-1 and HIV-2
Rod LTRs is lower than that of the SIVmac239 U3 region.
However, both HIV-1 and HIV-2 are the result of several
independent cross-species transmissions of SIVcpz and
SIVsm, respectively, into the human population (Hahn
et al., 2000). To date, seven HIV-2 subtypes (A–G) have
been described, but only A and B are largely represented
in the human population. HIV-2 Rod belongs to subtype
A. Thus, the LTR sequence analyzed is representative for
one of the two HIV-2 lineages that are epidemic in
humans. Overall, however, the HIV-2/SIVsm/mac group
of primate lentiviruses shows a remarkable genetic diver-
sity. Therefore, a larger number of LTR alleles derived
from different subtypes of HIV-1 and HIV-2 and their
respective original hosts, SIVcpz-infected chimpanzees
and SIVsm-infected sooty mangabeys, must be analyzedto evaluate whether the functional differences described in
this study might reflect a specific adaptation to the human
host.
SIVmac239 frequently causes simian AIDS in infected
macaques within 1 year after infection (Kestler et al.,
1989). HIV-1-infected individuals usually progress to dis-
ease within 8–10 years after infection. In contrast, indi-
viduals infected with HIV-2 show lower viral loads and
usually survive much longer than HIV-1 patients (Popper
et al., 1999). It remains unclear whether differences in the
transcriptional activation of the HIV-1, HIV-2, and SIVmac
LTRs might contribute to these marked differences in viral
pathogenicity. It is interesting to note, however, that
SIVmac, showing the highest functional redundancy in
U3 LTR elements, has the shortest and HIV-2, which
seems to have the lowest functional redundancy in the
U3 transcriptional elements, shows the longest clinical
latency period. Additional studies are required to define
the involvement of differential promoter–enhancer regula-
tion in the clinical outcome and the different length of the
clinical latency period in HIV-1, HIV-2, and SIVmac
infection.
Several previous studies have investigated the HIV-2
and SIVmac enhancers and defined several important
elements. However, most work focused on the character-
ization of factor binding sites or the analysis of transcrip-
tional activity in transient assays. In the present study, the
effect of mutations in the HIV-2 and SIVmac LTRs on
transcriptional activity and virus production was investi-
gated in the context of the integrated provirus in established
T-cell lines as well as primary PBMC and macrophages.
The impact of LTR mutations on virus replication largely
reflected the effects on proviral transcription observed in
single-cycle infection assays with VSV-G-pseudotyped
virus particles. However, even HIV-2 LTR variants show-
ing only background levels of luciferase activity in trans-
duced PBMC were still not entirely unable to spread in
PBMC cultures.
It was unexpected that the functional organization of
the HIV-2 Rod enhancer differs considerably from that of
SIVmac239. The HIV-2 and SIVmac U3 regions show a
much higher homology to each other than to the
corresponding region in the HIV-1 LTR. However, some
differences should be noted. For example, a TG-rich
element named the pets site is only found in the HIV-2,
but not in the SIVmac LTR. Furthermore, the PuB sites
are found at different locations, and SIVmac PuB1 and
PuB2 binding to Elf-1 seems to be much weaker com-
pared to HIV-2 (Pohlmann et al., 1998). Efficient tran-
scription of the HIV-2 LTR requires the presence of
several cis-regulatory elements. Single deletions in the
Sp1 and NF-nB sites or the upstream regulatory sequen-
ces have severe disruptive effects on enhancer–promoter
function, indicating that these regulatory elements need to
interact synergistically to allow efficient proviral transcrip-
tion and HIV-2 replication. In comparison, the disruptive
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in the SIVmac LTR are much less severe. Thus, despite
their sequence similarity and their common phylogenetic
origin, the organization of the HIV-2 enhancer has di-
verged considerably from those of SIVmac and HIV-1. A
more detailed analysis of LTRs derived from different
groups of HIV and SIV will be obligatory to better
understand their role in viral pathogenesis and disease
progression.Materials and methods
Mutant construction
The HIV-2 LTR variants analyzed are shown in Fig. 1.
The proviral sequence of HIV-2 Rod10 (Ryan-Graham and
Peden, 1995), kindly provided by Klaus Strebel (National
Institutes of Health, Bethesda, USA), was inserted into a
truncated pBR322 vector by standard cloning techniques
and subsequently modified for LTR analysis. To generate
pBR-Rod10Dnef, nucleotides 8725–8918 of the nef gene
were replaced by a linker containing NotI, NruI, and MluI
restriction sites, and the Nef ATG initiation codon was
changed to ACG by site-directed mutagenesis. This muta-
tion did not alter the predicted Env sequence. Thereafter, the
luciferase reporter gene was inserted into the unique NotI
and MluI sites. Nucleotides 6355–6358 were removed by
NsiI digest and Kleenow treatment to generate the env-
defective pBR-Rod10n-e-Luc construct (see Fig. 1). Site-
directed mutagenesis to generate the HIV-2 Rod LTR
variants was performed by spliced overlap extension PCR,
essentially as described previously (Pohlmann et al., 1998).
Briefly, the HIV-2 LTR was amplified with the outer primers
pRodLTR5 (5V-ACGCGT CGACCGCGGCTA-GCTGGA-
AGGGATGTTTTACAGTG-3V) and pRodLTR3 (5V-CCG-
GAATTCCCGGGAGA TCT TGCTTCTAACTGG-
CAGC-3V), and different sets of mutagenic inner primers
to generate DSp1 (9422–9448); DNF-kB (9390–9399);
DUS (9313–9389); DNF/Sp (9390–9448); and DNF/Sp/
US (9313–9448). The numbers refer to the deleted nucleo-
tides compared to the published HIV-2 Rod sequence
(GenBank accession number , M15390). The PCR products
were gel purified and inserted into the modified pBR322-
Vector containing either the env-defective full-length HIV-2
luciferase reporter virus or the pBR-Rod10Dnef construct
containing an intact env gene by using the unique MluI and
BglII sites (underlined) flanking the HIV-2 LTR. The 239wt
and modified SIVmac239 LTR sequences (Pohlmann et al.,
1998) were PCR amplified with pK76b (5V-CGACGCGT
ATTTAATAAAAAACAAGGGG - 3 Va n d pBR3
(5VAAGTGCCAC-CTGACGTCTAAG-3V) and inserted at
the 3V end of Rod10n-e-Luc or pBR-Rod10Dnef using the
MluI site upstream of the polypurine tract and the AatII site
in the flanking vector sequences (Fig. 1). Sequence analysis
confirmed that all proviral HIV-2 constructs contained onlythe intended changes in the HIV-2 or SIVmac239 3V LTRs
at their 3V ends.
Virus stocks
Virus stocks were generated and quantified as described
elsewhere (Hiebenthal-Millow and Kirchhoff, 2002). Brief-
ly, for the generation of pseudotyped viral particles, 293T
cells were co-transfected with 6 Ag DNA of the env-
defective proviral constructs and 3 Ag of a plasmid
(pHIT-G) expressing the Env glycoprotein of the vesicular
stomatitis virus (VSV-G). For the production of replication-
competent virus, 293T cells were transfected with 10 Ag of
the full-length HIV-2 Rod clones containing the mutated
LTR sequences. The p27 antigen concentrations were quan-
tified by using an HIV-ELISA provided by the NIH AIDS
Reagent Program.
Cell culture
293T cells were maintained in DMEM supplemented with
10% FCS. PM1, Jurkat, Sup-T1, and U937 cells were
maintained in RPMI 1640 with 10% FCS. Human peripheral
blood mononuclear cells (PBMCs) were isolated using
lymphocyte separation medium (Biochrom KG, Germany),
stimulated for 3 days with 4 Ag/ml phytohemagglutinin
(PHA), and cultured in RPMI 1640 medium with 20%
FCS and 50 U interleukin-2 (IL-2) per ml. For monocyte-
derived macrophage (MDM) generation, mononuclear cells
were isolated from fresh blood as described above. A total of
7.5  105 cells were seeded in 48-well dishes and cultured
for 1 week in RPMI 1640 medium supplemented with 10%
human serum (GibcoBRL, Carlsbad, CA), 50 U/ml GM-CSF
(Boehringer Mannheim, Germany), and antibiotics to allow
monocyte differentiation and adherence to the plates. Sub-
sequently, nonadherent cells were removed by extensive
washing with PBS. All cells were cultured at 37 jC and
5% CO2.
Reporter assays
PM1, Jurkat, SupT1, and U937 cells were seeded at 1 
105 in 24-well dishes and PBMC at 1  106 in 48-well
dishes and transduced with aliquots of virus stocks con-
taining 600 ng p24 antigen in a total volume of 250 Al or
150 Al medium, respectively. At 4 h after transduction, the
medium was added to a final volume of 1 ml or 500 Al,
respectively. At 3 or 4 days after infection, the cells were
pelleted, washed once with phosphate-buffered saline, and
resuspended in 50 Al lysis buffer (Promega, Madison, WI).
Cell debris was removed by centrifugation and 5 Al of the
supernatant was used to determine the total protein con-
centration with a commercial reagent (Bio-Rad, Laborato-
ries, Hercules, CA). Luciferase assays were performed
with the Promega assay system as recommended by the
manufacturer.
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PBMCs were seeded at 1  106 cells in 48-well dishes
and stimulated for 3 days with 4 Ag/ml phytohemagglutinin
(PHA) before infection. Infections were performed with low
doses of viral stocks containing 5 ng p27 antigen to
minimize the risk of undesired recombination between the
5V and 3V LTR. Cell-free culture supernatants were sampled
at regular intervals and stored at 20 jC. Genomic DNA
was extracted at the end of culture, and HIV-2 and SIV
LTRs were analyzed by PCR and sequence analysis essen-
tially as described previously (Mu¨nch et al., 2001), except
that different primers were used. Virus production was
measured by reverse transcriptase (RT) assay and quantitat-
ed using a phosphoimager assay as described (Hiebenthal-
Millow and Kirchhoff, 2002).Acknowledgments
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